Cargando...
Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
Background: In clinical practice, common problem polypharmacy could result in the increased risks of drug–drug interactions (DDIs). Co-administered imatinib (IMA) and voriconazole (VOR) as one treatment protocol in cancer patients with fungal infections are common.Purpose: The aim of the present stu...
Guardado en:
| Publicado en: | Infect Drug Resist |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6502443/ https://ncbi.nlm.nih.gov/pubmed/31118708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S199526 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|